Artificial intelligence (A.I.) has taken the world by storm recently. Hundreds of news stories have been written in the past week about projects that have used A.I.. A recent opinion piece dissected the effects of A.I. on integrity in academia. A sports journal compiled a list of the top ten basketball players of all time using A.I.. Another media outlet has turned to the technology to provide commentary during their broadcast of Wimbledon. But on Thursday, June 29, the first drug to ever be fully generated by artificial intelligence entered clinical trials with human patients.